The agreement was signed during a ceremony at the government headquarters in Egypt’s New Administrative Capital, attended by Prime Minister Mostafa Madbouly, who hailed the deal as a milestone in Egypt–US economic cooperation.
“The Egyptian pharmaceutical industry is key to driving new trade, investment, and mutual growth between Egypt and the United States,” Madbouly said.
The move aligns with President Abdel-Fattah El-Sisi’s directive to localize critical industries and open new export markets, particularly in the United States.
Madbouly added that the partnership would bring advanced American technology and expertise to Egypt, helping align local manufacturing with international quality standards and strengthening Egypt’s ability to compete globally.
The deal will support GYPTO Pharma’s efforts to obtain FDA certification, which would allow it to export to the US market—one of the largest pharmaceutical markets in the world.
Dawah Pharmaceuticals, a privately held company, manufactures and markets a range of FDA-approved drugs, including generic therapies across various dosage forms.
According to its website, the company is focused on expanding access to critical medicines in the US and beyond.
US Ambassador to Egypt Herro Mustafa Garg welcomed the agreement, calling it a “historic deal” that will introduce advanced US equipment and expertise into Egypt and expand pharmaceutical production across Africa and the Middle East.
GYPTO Pharma Chairman and Managing Director Amr Mamdouh said the partnership will invest in new manufacturing lines and systems that meet FDA standards, boosting the company’s production capacity and export potential.
Located in Khankah, Qalyubiya, north of Cairo, GYPTO Pharma spans 180,000 square metres and was inaugurated in 2021. Its annual production capacity ranges between 250 million and 300 million packages of medicines and vaccines.
Dawah Pharmaceuticals CEO Hossam Abdel-Maksoud reaffirmed the company’s commitment to transferring the technical know-how required for FDA compliance, saying the partnership would “enhance trade, innovation, and consumer access to quality medicines in both countries.”
Egypt's pharmaceutical exports reached $1 billion in the last fiscal year.
The government has set a target of tripling that figure to $3 billion by 2030.
Short link: